Topcu A, Yasin AI, Besiroglu M, Sucuoglu Isleyen Z, Alaca Topcu Z, Simsek M, Turk HM, Seker M, Soysal P. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients. Front Med ( Lausanne). 2024 Feb 19;11:1331246. doi: 10.3389/fmed.2024.1331246

Topcu A, Yurtsever I, Isleyen ZS, Besiroglu M, Yasin AI, Topcu ZA, Shbair AT, Toluk O, Simsek M, Seker M, Turk HM. The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy. Future Oncol. 2023 May;19(16):1139-1149. doi: 10.2217/fon-2022-1200

Topcu A, Ozturk A, Yurtsever I, Besiroglu M, Yasin AI, Turk HM, Seker M. The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma. Bosn J Basic Med Sci. 2022 Oct 23;22(6):982- 991. doi: 10.17305/bjbms.2022.7147.

Topcu A, Yasin AI, Shbair AT, Besiroglu M, Simsek M, Sucuoglu Z, Yurtsever I, Gucin Z, Seker M, Turk HM. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer. J Oncol Pharm Pract. 2022 Jan;28(1):242-246. doi: 10.1177/10781552211027931

Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398

Topcu A, Mursaloglu HH, Yalcinkaya Y, Karakurt S, Yagiz B, Alaca Z, Demir M, Coskun BN, Dalkilic E, Inanc N. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.

Clin Rheumatol. 2021 Sep;40(9): 3797-3805. doi: 10.1007/s10067-021- 05693-9.

Yasin AI, Uluganyan M, Isleyen ZS, Topcu A, Shbair AT, Simsek M, Besiroglu M, Ersoy YE, Türk HM, Seker M. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram. Support Care Cancer. 2024 Jul 8 ;32(8):492. doi: 10.1007/s00520-024-08702-0.

Simsek M, Besiroglu M, Akcakaya A, Topcu A, Yasin AI, Isleyen ZS, Seker M, Turk HM. Local interventions for colorectal cancer metastases to liver and lung. Ir J Med Sci. 2023 Dec;192(6):2635-2641. doi: 10.1007/s11845-023-03340-7.

Goktas Aydin S, Kavak EE, Topcu A, Bayramgil A, Akgul F, Kahraman S, Aykan MB, Altıntas YE, Helvaci K, Urun Y, Bilici A, Seker M, Sendur MAN, Olmez OF, Acikgoz O, Cicin I. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study.

Biomol Biomed. 2023 Nov 3;23(6):1089-1095. doi: 10.17305/bb.2023.9253

Sucuoglu Isleyen Z, Besiroglu M, Yasin AI, Simsek M, Topcu A, Smith L, Akagunduz B, Turk HM, Soysal P. The risk of malnutrition and its clinical implications in older patients with cancer. Aging Clin Exp Res. 2023 Nov;35(11):2675-2683. doi: 10.1007/s40520-023-02538-0.

Ünal Ç, Azizy A, Karabulut S, Taştekin D, Akyıldız A, Yaşar S, Yalçın Ş, Çoban E, Evrensel T, Kalkan Z, Oruç Z, Derin S, Turna ZH, Bayram D, Köş FT, Şendur MAN, Sever N, Ercelep Ö, Seyyar M, Kefeli U, Uygun K, Özçelik M, Ön S, Şanlı UA, Canaslan K, Ünek İT, Yücel KB, Özdemir N, Yazıcı O, Güzel HG, Salim DK, Göksu SS, Tatlı AM, Ordu Ç, Selvi O, Sakin A, Büyükbayram ME, Dursun B, Ürün Y, Arak H, Ağdaş G, Uğraklı M, Hendem E, Eryılmaz MK, Bilgin B, Topçu A, Şimşek M, Büyükşimşek M, Akay B, Erdal GŞ, Karataş F, Alan Ö, Çağlayan M, Kahvecioğlu FA, Demirci A, Paksoy N, Çetin B, Gümüş M, Ak N, Aydınalp Y, Paydaş S, Güven DC, Kılıçkap S,Sağlam S. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. Oncologist. 2023 Oct 3;28(10):875-884. doi: 10.1093/oncolo/oyad257

Ünal Ç, Tunçer G, Çopur B, Pilanci KN, Okutur KS, Yararbaş K, Alan Ö, Sakin A, Simsek M, Ünal İÖ, Topçu A, Alaca Topçu Z, Duymaz T, Ordu Ç. Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020-2022). Curr Med Res Opin. 2023 Jul; 39(7):987-996. doi: 10.1080/03007995.2023.2223917.

Gursoy P, Tatli AM, Erdem D, Goker E, Celik E, Demirci NS, Sakin A, Atci MM, Bayram E, Telli TA, Bilgin B, Bilici A, Akangunduz B, Balli S, Demirkazik A, Selçukbiricik F, Menekse S, Cavdar E, Ozturk A, Bekmez ET, Turhal S, Kilickap S, Yildirim HÇ, Oyan B, Aksoy A, Turkoz FP, Kut E, Katgi N, Sakalar T, Akyol M, Ellez Hİ, Topcu A, Erdoğan AP, Pilanci KN, Hedem E, Arak H, Akdeniz N, Alan Ö, Yapar B, Nart D, Yumuk PF. Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.J Cancer Res Clin Oncol.2023 Feb;149(2):865-875.doi: 10.1007/s00432-022-03984-5.

Goktas Aydin S, Cakan Demirel B, Bilici A, Topcu A, Aykan MB, Kahraman S, Akbıyık I, Atci MM, Olmez OF, Yaren A, Sendur MAN, Geredeli C, Seker M, Urun Y , Karadurmus N, Aydin A. Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer. Curr Med Res Opin. 2022 Oct;38(10):1751-1758. doi: 10.1080/03007995.2022.2108619.

Akdeniz N, Kaplan MA, İnanç M, Uncu D, Ergün Y, Küçüköner M, Demirci A, Şendur MAN, Beşiroğlu M, Topçu A, Yerlikaya H, Urakçi Z, Kiliçkap S, Işikdoğan A. The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas. 2022 Oct 1;51(9):1153-1159.

Aktürk Esen S, Ergun Y, Erol C, Arikan R , Er MM, Atci MM, Topçu A, Uçar G, Akagündüz B, Aykan MB, Özen M, Baytemur NK, Özçelik M, Şahin E, Güven D, Menekşe S, Ak N, Teker F, Kut E, Şakalar T, Alan Ö, Kaçan T, Turhal NS, Kiliçkap S, Türker S, Şendur MAN, Köstek O, Karaağaç M, Sakin A, Türk HM, Çağlayan D, Cihan Ş, Açikgöz Y, Uncu D. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer. Bosn J Basic Med Sci. 2022 Sep 16;22(5):818-825. doi: 10.17305/bjbms.2021.7069.

Shbair AT, Yasin AI, Topçu A, Coban G, Uzunoglu GD, Şimşek M. Metastatic Breast Carcinoma Mimicking Urothelial Carcinoma. Int J Surg Pathol. 2022 Jun;30(4):466-469. doi: 10.1177/10668969211067923.

Simsek M, Yasin AI, Besiroglu M, Topcu A, Sucuoglu Isleyen Z, Seker M, Turk HM. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer. J Med Virol. 2022 Sep;94(9):4138- 4143. doi: 10.1002/jmv.27835. Epub 2022 May 14

Yasin AI, Topcu A, Akuc MN, Türk HM, Soysal P. A comparison of anticholinergic burden in older patients with and without cancer. Future Oncol. 2021 Dec;17(36):5067-5075. doi: 10.2217/fon- 2021-0469.

Yasin AI, Topcu A, Shbair AT, Isleyen ZS, Ozturk A, Besiroglu M, Türk HM. Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic. Future Oncol.2021 Sep;17(25):3373-3381.doi: 10.2217/fon- 2020-1265

Besiroglu M, Demir T, Shbair ATM, Yasin AI, Topcu A, Turk HM. Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting? J Coll Physicians Surg Pak. 2021 Aug;31(8):932-936. doi: 10.29271/jcpsp.2021.08.932.

Bilgin SS, Gultekin MA, Yurtsever I, Yilmaz TF, Cesme DH, Bilgin M, Topcu A, Besiroglu M, Turk HM, Alkan A, Bilgin M. Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer. Magn Reson Med Sci. 2022 Jul 1;21(3 ):425-431. doi: 10.2463/mrms.mp.2020- 0183.

Besiroglu M, Shbair AT, Yasin AI, Topcu A, Turk HM, Demir T. Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme. J Coll Physicians Surg Pak. 2021 Jan;31(1):39-44. doi: 10.29271/jcpsp.2021.01.39.

Assoc. Prof. Atakan TOPÇU, M.D.